EVEX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
EVEX is not a good immediate buy for a Beginner focused on long-term investing with $50,000-$100,000 to deploy. The stock has some improving technical momentum and bullish options positioning, but the company is still loss-making, revenue is essentially flat, and the analyst consensus is mixed with recent price target cuts. For an impatient buyer, this is not a strong enough long-term entry right now; hold rather than buy.
The price closed at 2.87, essentially flat versus the previous close of 2.88, after a modest regular-session move earlier. Momentum is mildly constructive: MACD histogram is positive and expanding, RSI_6 at 58.722 is neutral-to-bullish, and moving averages are converging, which suggests a potential base-building phase rather than a strong breakout. Price is sitting near the pivot (2.893) with resistance at 3.06 and support at 2.727. A sustained move above 3.06 would improve the setup, but current trend strength is not decisive enough to call it a high-conviction buy.
["MACD histogram is positive and expanding, indicating improving short-term momentum.", "Options positioning is bullish, with a very low put-call open interest ratio.", "Analysts still see upside from current price levels, with targets between $4.70 and $6.", "Cantor Fitzgerald highlighted Embraer support, a large customer pipeline, and strong near-term liquidity."]
["Goldman Sachs cut its target to $4.70 and kept only a Neutral rating.", "JPMorgan and Cantor both lowered targets, showing a more cautious outlook on near-term ramp assumptions.", "Financials remain weak: Q4 revenue was 0, net income was -$63.9M, and EPS was -0.18.", "No Intellectia AI Stock Picker or SwingMax signal is present today.", "Insider and hedge fund trading trends are neutral, with no significant buying signal.", "No recent congress trading data is available."]
Latest quarter: 2025/Q4. Revenue was 0, showing no meaningful top-line growth. Net income improved to -$63.9M, but the company remains unprofitable. EPS was -0.18, also improved year over year but still negative. Overall, the latest quarter shows loss reduction rather than real operating growth, so the business is still in an early and highly speculative phase.
Recent analyst trend is slightly positive on rating stance but negative on price targets. JPMorgan kept Overweight but cut target to $6 from $7, Cantor kept Overweight but cut target to $6 from $7, and Goldman Sachs cut target to $4.70 from $5.28 while keeping Neutral. Wall Street pros see upside potential from liquidity, Embraer backing, and market leadership, but the cons are execution risk, conservative eVTOL ramp expectations, and continued lack of financial traction.
